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Abstract
Purpose: The purpose of this analysis was to investigate dose distribution of Three Dimensional Conformal Radiation Therapy
(3DCRT), Intensity Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) for Head and Neck
cancer using 3-dimensional PRESAGE® dosimeter. Method: Computer Tomography (CT) scans of Radiological Physics Center
(RPC) Head and Neck anthropomorphic phantom with both RPC standard insert and PRESAGE® insert were acquired
separated with Philipp’s CT scanner and both CT scans were exported via DICOM to the pinnacle treatment planning system
(TPS). Each plan was delivered twice to the RPC phantom first containing the RPC standard insert having Thermoluminescent
detectors (TLD) and film dosimeters and then again containing the PRESAGE® insert having three dimensional dosimeter
(PRESAGE®) by using a Varian True beam linear accelerator. After irradiation, the standard insert including point dose
measurement (TLD) and planner GafChromic® EBT film measurement was read using RPC standard procedure. The 3D dose
distribution from PRESAGE® was read out with the Duke Midsized optical scanner dedicated to RPC (DMOS-RPC). Dose
volume histogram (DVH), mean and maximal doses for organ-at-risk (OARs) were calculated and compared among each Head
and Neck technique. The prescription dose was same for all Head and Neck radiotherapy techniques which was 6.60 Gy per
friction. Beam profile comparison and gamma analysis were used to quantify agreement among film measurement, PRESAGE®
measurement and calculated dose distribution. Quality assurances of all plans were performed by using ArcCHECK method.
Results: VMAT delivered the lowest mean and maximal doses to organ at risk (spinal cord and parotid) than IMRT and 3DCRT.
Such dose distribution was verified by absolute dose distribution using TLD system. 2D gamma 5%/3 mm criteria of Pinnacle vs.
EBT2 film 3DCRT (92.34%), IMRT (92.3%) and VMAT (96.63%) in axial plan respectively. It was also found that agreement
between PRESAGE® and pinnacle along the axial, sagittal and coronal plans VMAT agreement was better than IMRT and
3DCRTplan excludes a 7 mm rim at the edge of the dosimeter using 2D gamma map criteria (±5%/3 mm) with 5% threshold
dose. Profile showed good agreement for all plans between film, PRESAGE® and pinnacle. 3D gamma was performed for
planning target volume (PTV) and organ at risks (OARs) VMAT and 3DCRT endow with better agreement than IMRT.
Conclusion: VMAT delivered lowered mean and maximal doses to organ at risk and better PTV coverage. TLD, EBT film and
PRESAGE® dosimeter has suggested that VMAT would be superior modality for the treatment of Head and Neck cancer than
IMRT and 3DCRT.
Keywords:RPC; 3DCRT; IMRT; VMAT; EBT2 FILM; TLD; PRESAGE®
Introduction
The requirement for accurate and quick practical three
dimension dosimetry has become a fundamental part of the
radiation delivery and complex treatment process. The ideal
dosimeter exhibits properties like tissue equivalent.1 The
scattering and absorption properties of the radiation
dosimeter should be comparable to the water.2 The
radiological properties and the formulation have been studies
by many writers and it was observed that PRESAGE®
(Heuris Inc., Skillman, NJ) has effective atomic number (7.6)
close to water (7.42).3 PRESAGE® is a radiochromic three
dimensional dose measuring dosimeter which is composed of
polyurethane and radiochromic components (Leuco dyes)
and halogen containing free radical initiator 4 that have
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an optical attenuation coefficient that changes linearly with
absorbed dose.5 The arrangement of PRESAGE® and an
optical CT scanner has addressed this require to measured
the dose in three dimensional (3D).6-7
The Radiological Physics Center (RPC) head and neck
credentialing analysis is usually done by hospital that want
to participate in the IMRT head and neck clinical trial
guideline of the Radiation Therapy Oncology Group
(RTOG).8 This analysis covers an IMRT plan created by the
participant institution or hospital with irradiation of RPC
head and neck phantom to encounter dose limit defined in
the RTOG guideline.
The TLD and EBT film were used to achieve required
dosimetric test into the RPC head and neck phantom. If the
measured dose is within 7%/4 mm gamma criteria with
calculated dose by Treatment Planning System (TPS) at a
limited number of points then participating institution passes
the credentialing analysis. It has been observed that 25%
institution fail to achieve require credentialing criteria at
first attempt, out of 342 irradiations.9 To solve such problem,
an urgent requirement for accurate three dimensional
dosimeter i.e. PRESAGE® has been introduced to maintain of
IMRT quality assurance.10-11.
Many studies had been done on PRESAGE® dosimeter that
shows acceptance agreement between measured doses to
calculated reference doses. Newton et al.12 indicated that
PRESAGE® 3D measurements were comprehensive and
efficient, because alignment errors are negligible, and all
parameters for multiple fields could be obtained from a
single dosimeter and scan. However, achieving accurate
superficial data (within 4 mm) is not yet feasible due to
optical surface artifacts. PDD values at 2 cm depth varied
from ∼72% for the 40 mm field, down to ∼55% for the 1
mm field. EBT and PRESAGE®PDDs agreed within ∼3% in
the typical therapy region (1-4 cm). At deeper depths the
EBT curves were slightly steeper (2.5% at 5 cm). These
results indicate good overall consistency between
ion-chamber, EBT2 and PRESAGE® measured OFs, PDDs,
and profiles.
It has been reported by Oldham et al.7 that good agreement
between PRESAGE® and Eclipse TPS distribution showed
by dose profile. Two dimensional gamma maps showed 98%
pass rate between all three techniques. The best agreement
between PRESAGE® and EBT were observed in the central
plane. Gama pass rate were 94% between normalized
PRESAGE® and Eclipse three dimensional distributions.
Some studies presented that PRESAGE®/Optical CT system
had excellent precision, accuracy, reproducibility and
robustness 3D dosimetry.13-14 Recently, it is reported that
ferrous xylenol-orange gel/optical–CT dosimetry system
were used to demonstrate the feasibility of three dimensional
dosimetry in RPC head and neck phantom.15
Previous work has focused on the fundamental dosimetric
characteristics of PRESAGE® and investigation of the
feasibility of the PRESAGE®/optical CT system for 3D
dosimetry. The aim of this study is to compare different
Head and neck radiotherapy techniques such as 3DCRT,
IMRT and VMAT by using PRESAGE® dosimeter with the
help of RPC credentialing phantom. To our knowledge this
dosimetric comparison is not done for these radiotherapy
techniques and this is first study of anthropomorphic Head
and Neck PRESAGE® dosimeter.
Methods and Materials
The RPC Insert and Phantom
The removable dosimetry insert and the RPC phantom
picture is shown in Figure 1(A). The RPC standard insert
contain three independent structures which are visible in
x-ray CT scan due to different densities. The names of
designated structure are planning target volume and two
OARs such as spinal cord and parotid. Insert also contain
three pieces of film and eight TLDs. Position of axial film
and TLDs can be seen in Figure 1(B) and other two film are
placed such that film form a single sagittal slice, when insert
is assembled. More ever, two TLDs are in the paroid superior
and inferior, two are in spinal cord superior and inferior and
four more are in PTV.
FIG. 1: (A) RPC Head and Neck an anthropomorphic Phantom; (B)
Standard RPC Insert which containing PTV and OARs with
dosimeter (EBT2, TLD).
Treatment planning of RPC standard insert
The RPC credentialing assessment comprises radiation of an
anthropomorphic Head and Neck phantom containing the
standard RPC insert with all treatment plans and comparing
the measured dose with the planned dose.8 The RPC
phantom was taken through the entire treatment planning
procedure by medical physicists as an actual patient. All
treatment plans were designed such that PTV coverage was
90% at least of the prescription dose for each technique and
got best plan to spare OARs.
The RPC instruction was used to maintain room temperature
and RPC head and neck phantom was filled with water.
When there were no air bubbles in water phantom then
insert was carefully placed inside phantom. To ensure
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consistent positioning during imaging and treatment,
coplanar surface marker were placed on the outside of the
phantom.
An x-ray CT scan was taken using a Philips CT scanner
(Philips Healthcare, Andover, MA) with a slice thickness of
1.5 mm to ensure that the TLDs could be seen. The CT scan
was imported into the Pinnacle 9.4 version treatment
planning system, where the structures (PTV, OARs) and
TLDs were manually contoured for all 3DCRT, IMRT and
VMAT plans. Treatment planning was done using VMAT
(four arc: 182o-178o, 180o-184o, 182o-178o, 180o-184o), Nine
field IMRT (beam angles: 200o, 240o, 280o, 320o, 0o, 40o, 80o,
120o and 160o) has been commonly used at MD Anderson
Cancer center, Houston and Four fields for 3DCRT (AP, PA,
Lt Lat and Rt Lat) were used. True Beam linear accelerator
was used for dose delivery with photon of 6MV energy and
C.C convolution algorithm was used for dose calculation.
Whereas adaptive convolve algorithm was used for
optimization for both IMRT and VMAT.
Quality assurance, TLD and EBT film analysis
Earlier to treatment, routine ArcCHECK (Sun Nuclear,
Melbourne, FL) QA procedures used at MD Anderson were
followed to check consistency of planned fluence with
delivered fluence for individual beams for all plans (3DCRT,
IMRT and VMAT). After ArcCHECK QA , the phantom was
transferred to the couch of a Varian True beam (Varian
Medical Systems, Palo Alto, CA), where the treatment was
delivered to the phantom. The treatment plans including the
dose calculation and insert were sent to RPC for dose
measurement and analysis. The RPC's standard procedures
were used to read the irradiated thermoluminescent
dosimeters and EBT2 films to decrease ambiguity. An
independent dose distribution authentication was performed
using EBT2 film (ISP Corp, Wayne, NJ, USA). The basic
reasons to use EBT2 film are its temporal stability, directional
independence and easy for self development.16
The delivered absolute dose to the mean computed dose
values inside the TLD contours were used to compare the
measured thermoluminescent dosimeter doses.13 In our
analysis, the irradiated films were sampled at a 0.3 mm × 0.3
mm pixel resolution and compared with the related treatment
plan dose distribution. The consequence of lower resolution
in film is acceptable and observed as sharper. A set of three
tiny pinholes in each film were used to register the film
measurements and planned dose distributions within the RPC
head and neck phantom. At RPC, the recorded dose in the
TLDs and the EBT film (henceforth called EBT dose) were
compared with the planned dose.8 A calibration curve was
prepared at the time of experimental irradiation as shown in
Figure 2. The films were digitized using a 48-bit
transmission/reflection flatbed photo scanner (Flat-Bed
Epson-10000XL). Each film was scanned in transmission
mode of three channels red, green and blue but only the red
channel was extracted for analysis because EBT has a
maximum response to red light at 633 nm.15 We did gamma
analysis with RPC film software and film dose were scaled
with TLD dose. The calibration curve was applied to the EBT
film to convert (OD) to dose.
FIG. 2: Calibration curve used to convert independent 2D dose
distribution verification was made using RPC GAFCHROMIC EBT2
film scanner.
3D dose measurement using PRESAGE® /optical-CT
The standard insert was removed and replaced with a
modified insert containing a PRESAGE® 3D dosimeter with
no disturbing the phantom alignment on the treatment
machine to reduce the setup errors. Treatment planning
and treatment delivery to the phantom with PRESAGE®
dosimetry insert was similar to that of the standard RPC
insert with only minor differences. Optical-CT was used for
3D dose readout from the irradiated PRESAGE® dosimeter.
A solid, radiochromic leuco dye doped polyurethane plastic
PRESAGE® dosimeter Heuris Inc., Skillman, NJ) was molded
to fit inside a plastic sleeve that was compatible with RPC
Head and Neck phantom as shown in Figure 3. The
PRESAGE® dosimeter along with the compatible sleeve is
hence onward called the PRESAGE® insert. Radiochromic
properties of PRESAGE® have been well characterized.2
The formulation used in this study had an effective Z
number of 7.6 and a physical density of 1.07 g/cm3.5,3
The radiochromic response was determined
spectrophotometrically using cuvette irradiations and was
found to be linear with sensitivity of 0.046 optical density
(OD) changes per cm per Gy. Using the cuvette sensitivity
data, it was estimated that a dose of 4 Gy would result in
an OD change. The treatment planning and delivery for the
phantom with PRESAGE® insert was similar to the
procedures for an actual patient. A CT scan of the phantom
with PRESAGE® insert was acquired by swapping with the
RPC insert. The surface markers already present on the
phantom were used to position the phantom in the same
orientation as that for the CT scan with RPC insert. The CT
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scan of the phantom with the PRESAGE® insert was
imported into the Pinnacle TPS and registered with the CT
scan of the phantom with the RPC insert using the auto
register tool, with the only exception that the prescription
dose was reduced from 6.6 to 4 Gy/fraction. This was
required because of the dose limit placed by the OD change
requirement of PRESAGE®. A dose of 6.6 Gy would have
induced a suboptimal OD change resulting in undesirable
artifacts for this particular formulation of PRESAGE®.17
FIG. 3: (A) PRESAGE® Insert containing plastic Insert and PRESAGE®; (B) DMOS reconstruction graphical user interfaces. Upper left quadrant
display projection images associated with the pre-irradiation scan and the lower left quadrant display projection images of the post-irradiation
scan. The Dosimeter was irradiated with nine field IMRT plan.
Before treatment, ArcCHECK QA procedures at MD
Anderson were followed to verify consistency of planned
fluence and delivered fluence for each beam. After all plans
QA i.e 3DCRT, IMRT and VMAT the phantom with
PRESAGE® insert was aligned on the treatment couch using
surface markers and the new plans with 4 Gy prescription
dose was delivered. A concern with scaling the prescription
dose was that it might cause differences in relative fluence,
MLC leaf motion, and relative dose distribution. To evaluate
the significance of changing prescription dose on the
consistency of the relative fluence between the two plans, the
ArcCHECK QA of all three plans measurements from the six
plans were analyzed. In addition, the Dynamic MLC log files
that were generated after delivery of each field were analyzed
to independently ascertain the relative consistency of MLC
leaf motion. After the treatment all plans, the PRESAGE®
dosimeter was kept refrigerated at 4°C and away from room
light for 12 hour then the 3D dose distribution was read out
using optical-CT scanner with the Duke Midsized optical
scanner (DMOS) dedicated for the RPC (DMOS-RPC) [Duke
University , Durham, NC] using 1 degree per step to produce
360 projection images. The DMOS-RPC scanner consists of
matched telecentric source and image lenses that provide a
fixed field of view (FOV). The DMOS was intended to use
with PRESAGE® to find out the linear change in optical
density against the ionizing radiation. The DMOS-RPC
scanner reduces optical refraction artifacts by surrounding the
PRESAGE® dosimeters within a refractive index matching
fluid. The fluid (mixture of octyl salicylate and octyl methoxy
cinnamate) was filtered before optical-CT scanning to remove
suspended impurities. The PRESAGE® dosimeters were
scanned before and after irradiation. The scanner was
configured for a voxel size of 1 mm3 comprised a linear
projection scan.
Data registration and dose analysis
The images from DMOS and Pinnacle TPS were exported to
the CERR (Washington University, St Louis, MO) a MATLAB
based software. Three types of data were available for
analyses of each plan: (1) Pinnacle calculated dose
distribution (2) 2D dose distribution of GAFCHROMIC EBT2
film (3) PRESAGE® dosimeter dose distribution for each plans
i.e. 3DCRT, IMRT and VMAT. The calculated dose
distribution from TPS (Pinnacle) was compared to measured
dose distribution from PRESAGE® and GafChromic EBT2 for
each plan with correspondence plans then again were
compared among each techniques of Head and Neck
radiotherapy. GafChromic EBT2 films doses were measured
by using RPC images software. Line profiles and Gamma
analysis were used to quantify the agreement between
calculated and measured dose distribution. Whereas 3D
gamma map were used between PRESAGE® dose distribution
and Pinnacle dose distribution in the specific region of
interest (ROI) i.e. PTV, spinal cord and parotid. The gamma
map used criteria of 5%/3 mm dose difference /distance to
agreement with maximum 5% threshold dose, which was
more stringent than currently used for RPC Head and Neck
credentialing protocols (7%/4 mm).
Results and Discussion
Earlier to a straight comparison of PRESAGE® with the
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gold-standard EBT film, it was compulsory to make obvious
that the relative dose distributions were identical in the
standard RPC insert (containing EBT) and the PRESAGE®
insert. Differences could arise from the scaling of the dose
prescription between these two plans (6.6 Gy for EBT and 4
Gy for the PRESAGE®) and the differences in CT numbers
between the PRESAGE® and EBT inserts.
Comparison of relative fluence maps measured by
ArcCHECK QA device showed that the relative fluences
were essentially identical between all these plans. With an
extremely high tolerance criterion of 3% dose difference and
3 mm DTA, a greater than 98% gamma pass rate was
achieved for all plans as shown in Figure 4.
FIG. 4: ArcCHECK Quality assurance (Q.A.) of 3DCRT (A), IMRT (B) and VMAT (C) plans with RPC standard insert and (D), (E) and (F) show
QA. of 3DCRT, IMRT and VMAT respectively with PRESAGE® insert.
FIG. 5: (A) Pinnacle® version 9.4 (TPS) dose distribution with dose prescription 6.6Gy in axial views of different plans 3DCRT, IMRT and
VMAT from left to right respectively with RPC standard insert; (B) Pinnacle® version 9.4 (TPS) dose distribution with dose prescription 4Gy in
axial views of different plans 3DCRT, IMRT and VMAT from left to right respectively with PRESAGE® insert scan.
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The comparison of relative dose distributions from the two
treatments plans (6.6 Gy and 4 Gy), as calculated by the
Pinnacle TPS are shown in Figure 5 for different Head and
Neck radiotherapy techniques. These represented isodose
lines in color wash are extracted from CERR. It is explored
dose distribution does not change by reducing the
prescription dose from 6.6 Gy to 4 Gy and also will agreed
with Sakhalkar et al.13 results.
Intercomparison of 3DCRT, IMRT and VMAT plans
using line profiles and gamma criteria among
PRESAGE® dose, EBT dose, and pinnacle calculation
Isodose line profile
Figure 6 illustrates the isodose line profile comparison taken
along the anterior-posterior of PTV for 3DCRT, IMRT and
VMAT plans between Pinnacle TPS with EBT 5(A, B, C) and
PRESAGE® 5(D, E, F). The Pinnacle dose distribution is
smoother with less noise than either of the measured dose
distribution as expected. Various comparatively minor
differences can be discerned between the distributions due
to setup error but trends are not readily apparent and it is
not possible to state whether the Pinnacle dose distribution
agrees more closely with one or the other of the measured
distributions. In some cases both measured distribution
appear to show a discrepancy with the Pinnacle dose
distribution. An example is the line profiles at the edges of
graph as shown in Figure 6. In general, consistent or
systematic trends were discerned and the distributions
appear very similar with discrepancies attributed to be
within the nose limit. Another consideration is that the two
measured distribution EBT and PRESAGE® actually
correspond to two independent deliveries of the same plans.
Any variation in the mechanism of deliveries would also
contribute to difference in the measured distribution.
FIG. 6: Comparison of dose profiles for Pinnacle (TPS) and film measurement (A, B, C), Pinnacle (TPS) and PRESAGE® (D, E, F) for 3DCRT,
IMRT and VMAT plan along Ant-Post profiles respectively.
FIG 7: (A) 2D Gamma 5%/3mm criteria of Pinnacle vs. PRESAGE® 3DCRT (96.35%), IMRT (96.65%) and VMAT (99.82%) in axial plan
respectively from left to right with 5% threshold dose through PTV; (B) 2D Gamma 5%/3mm criteria of Pinnacle vs. EBT2 film 3DCRT
(92.34%), IMRT (92.3%) and VMAT (96.63%) in axial plan respectively from left to right.
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Comparison of normalized 2D dose maps and dose profiles
from PRESAGE®, EBT, and Pinnacle distributions in the
central axial plane is shown in Figure 6. Dose profile
comparisons showed close agreement of PRESAGE® with
P innac l e . The agreement was good even in the
dose-gradient regions between the PTV and OARs, which
can be key sources of dosimetric errors. This difference
represents an uncertainty arising from the present
calibration procedure. The PRESAGE® dose in the
experimental large-volume insert was determined using the
calibration curve obtained from the irradiation of small
volume cuvettes using true beam machine. Part of the
difference may be due to a volume sensitivity effect which
needs further investigation. In addition, part of the
difference might be attributed to the different sensitivities of
the spectrophotometer used to measure the OD for cuvette
calibration and the Duke RPC scanner used to measure the
OD in the much larger experimental insert.19 In general, all
beam profiles of VMAT look better agreement then IMRT
and 3DCRT plans.
Gamma Map comparison
Gamma map investigation was used for further broad
authentication of the extent of agreement between Pinnacle,
EBT and PRESAGE® as shown in Figure 7. Gamma criteria of
5% dose difference and 3 mm DTA were used, substantially
less than the 7%, 4 mm criteria used in the RPC
credentialing test. A 2D gamma comparison between
PRESAGE® and the Pinnacle TPS distribution Figure 7(A)
yielded a high pass rate of 98% this number excludes a 5 mm
rim at the edge of the dosimeter, where edge artifacts occur.
2D gamma results were 96.35% (axial), 98.74% (sagittal),
97.76% (coronal) for 3DCRT, 95.23% (axial), 99.66%
(sagittal), 98.06% (coronal) for IMRT, 99.82% (axial) and
99.78% (sagittal), 98.38% (coronal) for VMAT plans between
PRESAGE® and pinnacle with 5% threshold dose through
PTV.
3D gamma showed excellent results in 3D volume of region
of interest (PTV and OARs) of all three plans between
PRESAGE® and Pinnacle as shown in Table 1. VMAT
illustrated better gamma results than the other two
techniques. The routine credentialing analysis comparing
Pinnacle with EBT as shown in Figure 7(B) was confirming
RPC credentialing criteria of 7%/4 mm. The disappointment
at the edge is caused by an edge artifact in the PRESAGE®
measurement.13
TABLE 1: 3D Gamma results with criteria of 5%/3mm along 5% threshold dose passing (Voxel%) Pinnacle (TPS) and PRESAGE®.
ROI VMAT (Voxel%) IMRT (Voxel%) 3DCRT (Voxel%)
PTV 98.14 92.1 96.93
Spinal Cord 99.9 85.3 99.9
Parotid 99.5 96.19 98.74
FIG. 8: Cumulative DVH for PTV (A), spinal cord (B) and Simulated Parotid Gland (C) for 3DCR., IMRT and VMAT.
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Dose volume histogram (DVH) comparison among
different Head and Neck radiotherapy techniques
DVH provide dose volume information for the organs
contoured in the treatment planning system. Figure 8
showed the dose volume contribution to the PTV from the
different Head and Neck radiotherapy techniques. During
treatment planning, it was made sure that prescription dose
was delivered at marked isocenter and PTV coverage was
calculated for each technique. PTV coverage was 90.80%,
95.80% and 95.82%, for 3DCRT, IMRT and VMAT,
respectively as shown in Figure 8(A), which reveals that
VMAT target coverage were better than other Head and
Neck techniques (IMRT and 3DCRT).
TABLE 2: Maximum and Mean doses for Organs-at-Risk (OARs) for
3DCRT. IMRT and VMAT
Techniques Parotid Spinal Cord
3DCRT Measn dose (Gy) 3.7 3.1
Max. dose (Gy) 4 5.6
IMRT Measn dose (Gy) 1.7 2.1
Max. dose (Gy) 2.9 4.2
VMAT Measn dose (Gy) 1.4 2.1
Max. dose (Gy) 2.3 4
VMAT delivered the lowest maximal doses than all other
studied techniques to spinal cord (4.0 Gy) and parotid (2.3
Gy) as shown in Figure 8(B and C). In comparison, maximal
doses for 3DCRT were 40% and 74% higher than VMAT for
spinal cord and parotid, respectively. Whereas, IMRT
delivered maximal 5% and 26% higher doses at spinal cord
and parotid than VMAT as shown in Table 2.
TLD results
TLD results passed the RPC 7% dose difference criteria, i.e.,
the measured dose agreed well with dose calculations within
the 7% dose difference. Results showed that the TLD dose
measurements in PTV were within 7% of the Pinnacle
calculations for all Head and Neck radiotherapy treatment
modalities. In addition to TLD dose measurement, EBT dose
measurement scaled to the TLD dose was used for relative
2D dosimetric verification in the central axial plane. TLD
results showed that VMAT plans delivered lower doses to
OARs as compared to other IMRT and 3DCRT plans and
each plan was delivered three times for the reproducibility as
shown in Figure 9.
FIG. 9: TLD [Site1-2(Parotid sup-inf), 3-4(spinal Cord sup-inf)] Doses to organ at risk during head and neck radiotherapy techniques (3DCRT,
IMRT, VMAT).
Conclusion
VMAT delivered lowered mean and maximal doses to OARs
with better PTV coverage during Head and Neck
radiotherapy. This work demonstrates the dosimetric
comparison and the implementation of the PRESAGE®
/optical-CT 3D dosimetry system in the RPC Head and Neck
phantom using different Head and Neck radiotherapy
treatment modalities i.e. 3DCRT, IMRT and VMAT. The
PRESAGE® measurement was hence used as a 3D standard to
compare the accuracy of Pinnacle 3D dose calculations. The
Pinnacle dose calculations showed good agreement (99%
pass rate) with gamma criteria of 5% dose difference and 3
mm DTA with the PRESAGE® measurement at region of
interest (ROI) 3D volume (PTV and OARs) for VMAT and
3DCRT plans and 95% pass rate for complex nine field IMRT
plan too. TLD, EBT film and PRESAGE® dosimeters suggest
that VMAT is better for the treatment of Head and Neck
cancer than IMRT and 3DCRT.
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